Molecular Diagnostics, the IVD industry’ segment, refers to the tests measuring DNA and RNA, as well as various products of metabolism to discover mutations, specific genotypes or any biochemical alterations which may be linked to certain health states or disease conditions. This science owns its emergence to the advancements in biology that have deepened the knowledge of the mechanisms of molecular-level processes, both normal and malignant.
Molecular Diagnostics is by far the most hastily progressing sector. The oncoming decade will be ear-marked by far-reaching advances in reagent and automation systems, along with the advent of a generous assortment of novelties set to inevitably call for innovative marketing techniques. The percentage of market penetration into day-to-day habitual clinical lab settings, though, will revolve around the arrival of money’s worth and automatized systems with amplification techniques. Some of the firms reigning over the market are Abbott Diagnostics, Celera, Sysmex Corporation, Roche Diagnostics, Qiagen N.V., Siemens Medical Solutions Diagnostics, and more.
The research reports from this Catalogue look at the Molecular Diagnostics Market on every imaginable geography level, covering key technology and medical trends. The issues mentioned in the research reports are varied, ranging from market sizing, share and segmentation to new product introductions and regulatory landscape. Further, the research reports highlight market penetration strategies, potential enter barriers, competitive profiles, besides offering the Molecular Diagnostics Market forecasts.
Publications found:
1,148
Sort by:
The 2027-2032 World Outlook for Digital PCR
US$ 1,195.00
This study covers the world outlook for digital PCR across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Molecular Diagnostics IVD
US$ 1,195.00
This study covers the world outlook for molecular diagnostics IVD across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Multiplexed Diagnostics
US$ 1,195.00
This study covers the world outlook for multiplexed diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Nucleic Acid Test Kits
US$ 1,195.00
This study covers the world outlook for nucleic acid test kits across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for PoC Molecular Diagnostics
US$ 1,195.00
This study covers the world outlook for PoC molecular diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
Real-time PCR, Digital PCR & End-point PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Quantitative, Digital, Endpoint), By Product (Consumables & Reagents, Instruments, Software & Services), By Application (Clinical, Research), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Real-time PCR, Digital PCR & End-point PCR Market will grow from USD 9.01 Billion in 2025 to USD 13.12 Billion by 2031 at a 6.46% CAGR. The Global Real-time PCR, Digital PCR & End-point PCR...
January 2026
185 pages
C-Reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type (ELISA, Chemiluminescence Immunoassay), By Detection Range (hs-CRP, Conventional CRP), By Disease Area (Cancer, Lupus), By End-use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global c-reactive protein (CRP) testing market size is expected to reach USD 1.77 billion by 2025, ... women is expected to play a major role in the CRP testing market over the forecast period. Increase in funds provided to academic ... is ultimately driving the growth of the C-reactive protein testing market.
January 2026
200 pages
Digital PCR Market - Forecast from 2026 to 2031
US$ 3,950.00
The digital PCR market is expected to expand at a 13.97% CAGR, reaching USD 2151.54 million in 2031 from USD 981.865 million in 2025. The digital PCR (dPCR) market represents a significant technologic...
January 2026
151 pages
Cancer Biopsies Market 2026
US$ 2,999.00
The Cancer Biopsies Market was valued at in and is anticipated to reach by , at a CAGR of 0.138 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...
December 2025
207 pages
Hemato Oncology Testing Market - 2022
US$ 2,999.00
The Hemato Oncology Testing Market was valued at USD 280 million in 2022 and is anticipated to reach by , at a CAGR of 0.048 from 2026 to 2032. The report delivers in-depth insights into key market dy...
December 2025
210 pages
Latin America Digital Pathology Market 2026
US$ 2,999.00
The Latin America Digital Pathology Market was valued at in and is anticipated to reach by , at a CAGR of 0.1009 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...
December 2025
200 pages
Liver Cancer Diagnostics Market - 2022-2030
US$ 2,999.00
The Liver Cancer Diagnostics Market was valued at USD 8.6 billion in 2022 and is anticipated to reach USD 14.1 billion by 2030, at a CAGR of 0.066 from 2026 to 2032. The report delivers in-depth insig...
December 2025
220 pages
Multiplexed Diagnostics Market 2026
US$ 2,999.00
The Multiplexed Diagnostics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
December 2025
219 pages
North America Digital Pathology Market 2026
US$ 2,999.00
The North America Digital Pathology Market was valued at in and is anticipated to reach by , at a CAGR of 0.125 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inclu...
December 2025
217 pages
PD-L1 and PIK3CA Testing Product Market 2026
US$ 2,999.00
The PD-L1 and PIK3CA Testing Product Market was valued at in and is anticipated to reach by , at a CAGR of 0.1845 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inc...
December 2025
210 pages
Transplant Diagnostics Market 2026
US$ 2,999.00
The Transplant Diagnostics Market was valued at in and is anticipated to reach by , at a CAGR of 0.077 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
December 2025
223 pages
Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location (Point Of Care, Self-Test), By Technology (PCR, ISH, INAAT), By Application (Oncology, Infectious Diseases), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
... such as HPV and influenza is anticipated to be the key driver for molecular diagnostics market growth. Moreover, increasing demand for rapid and accurate ... key factors attributing to its large market share. Increasing demand for user-friendly, portable, and rapid analysis devices is a key factor resulting ...
December 2025
270 pages
Minimal Residual Disease Testing Market 2026
US$ 2,999.00
The Minimal Residual Disease Testing Market was valued at in and is anticipated to reach by , at a CAGR of 0.125 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...
December 2025
200 pages
Oncology Molecular Diagnostics Market - 2024-2033
US$ 2,999.00
The Oncology Molecular Diagnostics Market was valued at US$ 3.79 Billion in 2024 and is anticipated to reach US$ 6.46 Billion by 2033, at a CAGR of 0.062 from 2026 to 2032. The report delivers in-dept...
December 2025
186 pages
HLA Typing for Transplant Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service (Reagents & Consumables, Instruments, Software & Services), By Technology (Molecular Assay Technologies, Non-molecular Assay Technologies), By Application (Diagnostic Applications, Antibody Screening, Chimerism Monitoring, Research Applications, Others), By Transplant Type (Solid Organ Transplant, Soft Tissue Transplant) Region and Competition, 2020-2030F
US$ 4,500.00
The Global HLA Typing for Transplant Market, valued at USD 1.92 Billion in 2024, is projected to experience a CAGR of 6.91% to reach USD 2.87 Billion by 2030. Human Leukocyte Antigen (HLA) typing for...
December 2025
185 pages
HLA Typing Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Technique (Molecular Assay, Sequenced-based Molecular Assay, Non-Molecular Assay), By Application (Diagnosis, Research), By Product (Instruments, Reagents & Consumables, Software & Services), By End User (Commercial Service Providers, Hospitals and Transplant Centers, Research Labs & Academic Institutes), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global HLA Typing Market, valued at USD 1.92 Billion in 2024, is projected to experience a CAGR of 6.50% to reach USD 2.80 Billion by 2030. Human Leukocyte Antigen (HLA) typing constitutes the pro...
December 2025
185 pages
Middle East Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker, By Technology, By Sample Type, By Application, By Clinical Application, By End Use, By Product, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The Middle East liquid biopsy market size was valued at USD 104.76 million in 2024 and is projected to reach USD 233.95 billion by 2033, growing at a CAGR of 9.28% from 2025 to 2033. The market is dri...
November 2025
150 pages
Bardet-Biedl Syndrome Diagnostics Market 2026
US$ 2,999.00
The Bardet-Biedl Syndrome Diagnostics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inclu...
November 2025
210 pages
Breast Cancer Liquid Biopsy Market - 2023-2031
US$ 2,999.00
The Breast Cancer Liquid Biopsy Market was valued at US$ 1.6 billion in 2023 and is anticipated to reach US$ 7.98 billion by 2031, at a CAGR of 0.232 from 2026 to 2032. The report delivers in-depth in...
November 2025
220 pages
Celiac Disease Testing Market 2026
US$ 2,999.00
The Celiac Disease Testing Market was valued at in and is anticipated to reach by , at a CAGR of 0.077 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
November 2025
220 pages
Cervical Cancer Diagnostics Market 2026
US$ 2,999.00
The Cervical Cancer Diagnostics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
November 2025
219 pages
Congenital Adrenal Hyperplasia Diagnosis Market 2026
US$ 2,999.00
The Congenital Adrenal Hyperplasia Diagnosis Market was valued at in and is anticipated to reach by , at a CAGR of 0.077 from 2026 to 2032. The report delivers in-depth insights into key market dynami...
November 2025
223 pages
Digital PCR Market 2026
US$ 2,999.00
The Digital PCR Market was valued at in and is anticipated to reach by , at a CAGR of 0.074 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth...
November 2025
210 pages
Epigenetics Drugs and Diagnostic Technologies Market 2026
US$ 2,999.00
The Epigenetics Drugs and Diagnostic Technologies Market was valued at in and is anticipated to reach by , at a CAGR of 0.197 from 2026 to 2032. The report delivers in-depth insights into key market d...
November 2025
218 pages
Europe Theranostics Market - 2022-2031
US$ 2,999.00
The Europe Theranostics Market was valued at US$ 501.86 million in 2022 and is anticipated to reach US$ 1,104.22 million by 2031, at a CAGR of 0.106 from 2026 to 2032. The report delivers in-depth ins...
November 2025
210 pages
Exosome Diagnostics and Therapeutics Market 2026
US$ 2,999.00
The Exosome Diagnostics and Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.2 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, in...
November 2025
223 pages
Genotyping Assay Market 2026
US$ 2,999.00
The Genotyping Assay Market was valued at in and is anticipated to reach by , at a CAGR of 0.1999 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
207 pages
Immunohistochemistry Market - 2022-2031
US$ 2,999.00
The Immunohistochemistry Market was valued at US$ 2,302.79 million in 2022 and is anticipated to reach US$ 4,240.65 million by 2031, at a CAGR of 0.081 from 2026 to 2032. The report delivers in-depth...
November 2025
218 pages
